The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries:...
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study
About this item
Full title
Author / Creator
Portnoy, Allison , Clark, Rebecca A. , Quaife, Matthew , Weerasuriya, Chathika K. , Mukandavire, Christinah , Bakker, Roel , Deol, Arminder K. , Malhotra, Shelly , Gebreselassie, Nebiat , Zignol, Matteo , Sim, So Yoon , Hutubessy, Raymond C. W. , Baena, Inés Garcia , Nishikiori, Nobuyuki , Jit, Mark , White, Richard G. and Menzies, Nicolas A.
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Tuberculosis (TB) is preventable and curable but eliminating it has proven challenging. Safe and effective TB vaccines that can rapidly reduce disease burden are essential for achieving TB elimination. We assessed future costs, cost-savings, and cost-effectiveness of introducing novel TB vaccines in low- and middle-income countries (LMICs) for a ra...
Alternative Titles
Full title
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study
Authors, Artists and Contributors
Author / Creator
Clark, Rebecca A.
Quaife, Matthew
Weerasuriya, Chathika K.
Mukandavire, Christinah
Bakker, Roel
Deol, Arminder K.
Malhotra, Shelly
Gebreselassie, Nebiat
Zignol, Matteo
Sim, So Yoon
Hutubessy, Raymond C. W.
Baena, Inés Garcia
Nishikiori, Nobuyuki
Jit, Mark
White, Richard G.
Menzies, Nicolas A.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_2777430352
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2777430352
Other Identifiers
ISSN
1549-1676,1549-1277
E-ISSN
1549-1676
DOI
10.1371/journal.pmed.1004155
